HC Wainwright & Co. Initiates Coverage On Biohaven With Buy Rating, Announces Price Target of $50

Benzinga ·  Dec 22, 2023 06:12

HC Wainwright & Co. analyst Douglas Tsao initiates coverage on Biohaven (NYSE:BHVN) with a Buy rating and announces Price Target of $50.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment